← Back to Clinical Trials
Recruiting NCT07328295

NCT07328295 Additional Effects of Thoracic Spine Mobilization Combined With Glenohumeral Joint Mobilization on Pain, Range of Motion, and Functional Disability in Adhesive Capsulitis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07328295
Status Recruiting
Phase
Sponsor Foundation University Islamabad
Condition Adhesive Capsulitis
Study Type INTERVENTIONAL
Enrollment 34 participants
Start Date 2025-01-15
Primary Completion 2025-12-30

Trial Parameters

Condition Adhesive Capsulitis
Sponsor Foundation University Islamabad
Study Type INTERVENTIONAL
Phase N/A
Enrollment 34
Sex ALL
Min Age 40 Years
Max Age 65 Years
Start Date 2025-01-15
Completion 2025-12-30
Interventions
Thoracic spine mobilization with Glenohumeral joint mobilizationGlenohumeral joint mobilization only

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Adhesive capsulitis is a debilitating shoulder condition characterized by pain, restricted range of motion (ROM), and significant functional limitations. Conventional treatment primarily targets the glenohumeral joint, often neglecting the role of regional interdependence, particularly the thoracic spine's influence on shoulder mobility. Emerging evidence suggests that thoracic spine mobility plays a crucial role in optimizing shoulder mechanics, yet its therapeutic application in adhesive capsulitis remains underexplored. This study aims to investigate the additional effects of thoracic spine mobilization combined with glenohumeral joint mobilization, providing a more comprehensive rehabilitation approach to enhance pain relief, ROM, and functional outcomes. A randomized controlled trial (RCT) will be conducted over one year at the Rehabilitation Department of Fauji Foundation Hospital (FFH) after obtaining ethical approval. Participants diagnosed with adhesive capsulitis will be selected through non-probability purposive sampling based on predefined inclusion and exclusion criteria. Subjects will be randomly assigned to either the experimental group receiving thoracic spine mobilization alongside glenohumeral joint mobilization or the control group receiving glenohumeral joint mobilization alone. Randomization will be conducted using the coin toss method and block randomization to ensure balanced subject distribution. Outcome measures include the Numeric Pain Rating Scale (NPRS) for pain assessment, the Shoulder Pain and Disability Index (SPADI) for functional disability evaluation, and a goniometer for ROM measurement. Baseline and post-treatment scores will be statistically analyzed using SPSS to determine intervention effectiveness. By integrating thoracic spine mobilization into standard treatment, this study seeks to refine clinical rehabilitation protocols, improve functional recovery, and enhance patient outcomes. Findings may contribute to evidence-based practice, supporting the inclusion of thoracic spine mobilization in treatment guidelines for adhesive capsulitis.

Eligibility Criteria

Inclusion Criteria: * • Both male and female patients with a primary complaint of unilateral or bilateral shoulder pain * Pain has persisted for at least 3 to 4 months * Decreased shoulder ROM observed, including external shoulder rotation, abduction, internal rotation, and flexion * Age range between 40 to 65 years * Diagnosed with stage 2nd or 3rd of the disease. Exclusion Criteria: * • Patients if they had any shoulder pain resulting from systematic disease such as Rheumatoid Arthritis (morning stiffness \> 1 hour, multiple small joints pain/swelling) Infection, Tumors, and conditions like myelopathy (Hoffman's sign). * Recent shoulder joint fracture/ trauma. * Thoracic Outlet Syndrome (Roos test). * The presence of Cervical radiculopathy (Spurling's test)

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology